8-Acetyl-7-methoxycoumarinCAS# 89019-07-8 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 89019-07-8 | SDF | Download SDF |
PubChem ID | 14116752 | Appearance | Powder |
Formula | C12H10O4 | M.Wt | 218.2 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 8-acetyl-7-methoxychromen-2-one | ||
SMILES | CC(=O)C1=C(C=CC2=C1OC(=O)C=C2)OC | ||
Standard InChIKey | OTYBDEHZHXKGBO-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C12H10O4/c1-7(13)11-9(15-2)5-3-8-4-6-10(14)16-12(8)11/h3-6H,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Reference standards. |
8-Acetyl-7-methoxycoumarin Dilution Calculator
8-Acetyl-7-methoxycoumarin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.583 mL | 22.9148 mL | 45.8295 mL | 91.659 mL | 114.5738 mL |
5 mM | 0.9166 mL | 4.583 mL | 9.1659 mL | 18.3318 mL | 22.9148 mL |
10 mM | 0.4583 mL | 2.2915 mL | 4.583 mL | 9.1659 mL | 11.4574 mL |
50 mM | 0.0917 mL | 0.4583 mL | 0.9166 mL | 1.8332 mL | 2.2915 mL |
100 mM | 0.0458 mL | 0.2291 mL | 0.4583 mL | 0.9166 mL | 1.1457 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Hydrocotarnine hydrobromide
Catalog No.:BCN0003
CAS No.:5985-00-2
- N-Methylcolchicine
Catalog No.:BCN0002
CAS No.:7336-40-5
- 2-(4-Methoxybenzal)acetophenone
Catalog No.:BCN0001
CAS No.:959-33-1
- 8-p-Coumaroylharpagide
Catalog No.:BCN0152
CAS No.:87686-74-6
- trans-5-Hydroxyferulic acid
Catalog No.:BCN9999
CAS No.:110642-42-7
- 7-Methoxyflavone
Catalog No.:BCN9998
CAS No.:22395-22-8
- Oxyacanthine hydrochloride
Catalog No.:BCN9997
CAS No.:15352-74-6
- 3,4-Dimethoxychalcone
Catalog No.:BCN9996
CAS No.:5416-71-7
- 2',3,5,7-Tetrahydroxyflavone
Catalog No.:BCN9995
CAS No.:480-15-9
- 4-Hydroxyquinoline
Catalog No.:BCN9994
CAS No.:611-36-9
- Cytochalasin C
Catalog No.:BCN9993
CAS No.:22144-76-9
- Geranylacetate
Catalog No.:BCN9992
CAS No.:105-87-3
- Shatavarin IV
Catalog No.:BCN0005
CAS No.:84633-34-1
- N-trans-p-Coumaroyltyrosine
Catalog No.:BCN0006
CAS No.:77201-66-2
- Chamigrenol
Catalog No.:BCN0007
CAS No.:19822-80-1
- Harmol hydrochloride monohydrate
Catalog No.:BCN0008
CAS No.:40580-83-4
- Daidzein 7-O-glucuronide
Catalog No.:BCN0009
CAS No.:38482-80-3
- Chamaemeloside
Catalog No.:BCN0010
CAS No.:173356-77-9
- Withanoside IV
Catalog No.:BCN0011
CAS No.:362472-81-9
- Phyllanthusiin C
Catalog No.:BCN0012
CAS No.:142674-52-0
- beta-Cryptoxanthin
Catalog No.:BCN0013
CAS No.:472-70-8
- Cyanidin-3-O-rhamnoside chloride
Catalog No.:BCN0014
CAS No.:38533-30-1
- Phloroglucinol dihydrate
Catalog No.:BCN0015
CAS No.:6099-90-7
- 3-Methoxyflavon
Catalog No.:BCN0016
CAS No.:7245-02-5
Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells.[Pubmed:25461322]
Eur J Med Chem. 2015 Jan 27;90:221-31.
Based on the reported anticancer activity of coumarin and pyrazoline derivatives, the present investigation dealt with the design and synthesis of coumarin derivatives bearing diversely substituted pyrazoline moieties 7-10. The non-cyclic isosteres 11a-e of compounds 10a-e were synthesized for comparative reasons. The target compounds were synthesized from 8-Acetyl-7-methoxycoumarin that underwent Claisen-Schmidt condensation with various aldehydes to give the chalcones 6a-e, followed by reaction with hydrazine hydrate, phenyl hydrazine or semicarbazide under the appropriate conditions. Cytotoxicity of the synthesized compounds was evaluated in vitro against liver HepG2 cell line. Compounds were active in the nanomolar range. The most active compounds were investigated for their telomerase inhibition and proapoptotic activities.